Alzheimer’s disease doesn’t arrive suddenly. Instead, it emerges slowly, beginning with subtle changes that might be dismissed as normal aging before progressing through increasingly serious stages of ...

News about Alzheimer's rose to the forefront in 2025, as the FDA approved the first diagnostic blood test and drugmakers reported 3-year outcomes for both anti-amyloid drugs, lecanemab (Leqembi) and ...

An autoinjector to administer Leqembi to patients with early-stage Alzheimer’s disease had high degrees of satisfaction for utility, feasibility and convenience for use at home, according to a poster.

SEATTLE — An estimated 7.2 million Americans age 65 and older are living with Alzheimer's disease, according to an extensive 2025 report compiled by the Alzheimer's Association. While there is still ...

In two studies, semaglutide failed to slow decline in thousands of people with early stages of Alzheimer's disease.

Dr. Morris answers the question: 'Age For Beginning Stages of Alzheimer's?' May 4, 2009 -- Question: At what age might one expect to see the beginning stages of Alzheimer's? Answer: The No. 1 risk ...

CHICAGO, Nov. 24, 2025 /PRNewswire/ -- The Alzheimer's Association is disappointed that the evoke and evoke+ clinical trials did not demonstrate a statistically significant reduction in Alzheimer's ...

Earlier studies have identified a relationship between sleep and Alzheimer’s disease. A new study looks in detail at sleep phases, brain changes, and Alzheimer’s disease. According to the results, ...

"Medical Journeys" is a set of clinical resources reviewed by physicians, meant for the medical team as well as the patients they serve. Each episode of this journey through a disease state contains ...